Table 2

Patient characteristics at transplantation

CRnCRVGPRPRSDPD
Hemoglobin level, g/dL, mean ± SD11.8 ± 1.511.6 ± 1.711.3 ± 1.711.2 ± 1.79.7 ± 1.211.1 ± 1.2
Serum creatinine level, μmol/Lm mean ± SD106 ± 13288 ± 2680 ± 26110 ± 61102 ± 4682 ± 21
Serum calcium level, μmol/Lm mean ± SD232 ± 22230 ± 20227 ± 15227 ± 27232 ± 12225 ± 24
Serum albumin level, g/Lm mean ± SD30 ± 1629 ± 1530 ± 1531 ± 1330 ± 734 ± 7
β2 microglobulin ≥ 2.5 mg/L, %295242434260
LDH > normal limit, %9116131735
PS ≥ 2 (ECOG), %92122144150
Pre-HDT/SCT different chemotherapy combinations ≥ 2, %243642506278
Time from diagnosis to HDT/SCT, mo, mean ± SD15 ± 2216 ± 1916 ± 1624 ± 314260
Pre-HDT/SCT response status: CR or nCR*/PR/SD/PD, %23/61/2/1418/58/6/182/72/6/200/73/6/210/33//37/300/42/42/14
  • LDH indicates lactate dehydrogenase; PS, performance status; and ECOG, Eastern Cooperative Oncology Group.

  • * Electrophoresis was negative. No immunofixation data were available.